Published in Acta Pharmacol Sin on August 25, 2014
Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma model. Oncol Lett (2016) 0.77
Impact of Platelets and Platelet-Derived Microparticles on Hypercoagulability Following Burn Injury. Shock (2016) 0.77
Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants. Clin Transl Med (2017) 0.75
Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol (2007) 17.18
Membrane vesicles as conveyors of immune responses. Nat Rev Immunol (2009) 14.72
Mechanisms of thrombus formation. N Engl J Med (2008) 4.67
Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta (2012) 4.33
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med (2010) 4.32
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine (2011) 3.79
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest (1999) 3.19
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood (2003) 3.04
Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res (2010) 3.03
Microvesicles as mediators of intercellular communication in cancer--the emerging science of cellular 'debris'. Semin Immunopathol (2011) 2.78
Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest (1997) 2.75
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol (2007) 2.70
Microparticles in cardiovascular diseases. Cardiovasc Res (2003) 2.62
Effects of severe hypertension on endothelial and platelet microparticles. Hypertension (2003) 2.53
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood (2000) 2.51
Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature (1992) 2.48
Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol (2004) 2.42
Cellular microparticles: what are they bad or good for? J Thromb Haemost (2003) 2.41
Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost (2001) 2.38
Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J Thromb Haemost (2009) 2.33
Microparticles in hemostasis and thrombosis. Circ Res (2011) 2.26
Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol (2006) 2.23
Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood (2004) 2.16
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res (2009) 2.04
Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol (2005) 1.96
Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost (2004) 1.96
Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest (1997) 1.90
The role of von Willebrand factor in thrombus formation. Thromb Res (2007) 1.85
Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem (1999) 1.82
Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest (1987) 1.74
Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol (2007) 1.72
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost (2008) 1.70
Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol (1994) 1.66
Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res (2003) 1.66
Emerging mechanisms of neutrophil recruitment across endothelium. Trends Immunol (2011) 1.65
Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem (1989) 1.63
Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler Thromb Vasc Biol (2002) 1.62
Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes (2002) 1.61
Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol (2006) 1.60
Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem (1990) 1.59
Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med (2009) 1.58
Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol (2011) 1.57
Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke. Am J Pathol (2013) 1.54
Plasma microparticles and vascular disorders. Br J Haematol (2007) 1.52
Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol (1999) 1.50
High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood (1996) 1.50
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43
Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost (2003) 1.41
The presence and release of tissue factor from human platelets. Platelets (2002) 1.37
Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol (2001) 1.35
Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg (2005) 1.34
High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles--brief report. Arterioscler Thromb Vasc Biol (2012) 1.31
Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol (2011) 1.26
Microparticles in angiogenesis: therapeutic potential. Circ Res (2011) 1.24
Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis (1995) 1.23
Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation. Thromb Haemost (2008) 1.22
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood (2002) 1.21
Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J Thromb Haemost (2009) 1.19
Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nat Commun (2012) 1.18
The role of microvesicles in tissue repair. Organogenesis (2011) 1.15
Evidence of platelet activation in multiple sclerosis. J Neuroinflammation (2008) 1.15
Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo. J Thromb Haemost (2003) 1.09
Novel leukocyte agonists are released by endothelial cells exposed to peroxide. J Biol Chem (1992) 1.09
Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood (1984) 1.09
The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol (2010) 1.08
Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. J Thromb Haemost (2004) 1.06
Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine. Am J Transplant (2011) 1.04
Tobacco smoke induces the generation of procoagulant microvesicles from human monocytes/macrophages. Arterioscler Thromb Vasc Biol (2010) 1.04
Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification. Arterioscler Thromb Vasc Biol (2012) 0.98
Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles. Arterioscler Thromb Vasc Biol (2006) 0.98
Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost (2005) 0.95
Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thromb Haemost (2011) 0.93
Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes (2012) 0.93
Membrane microparticle determination: at least seeing what's being sized! J Thromb Haemost (2009) 0.93
Participation of protein kinases in complement C5b-9-induced shedding of platelet plasma membrane vesicles. Blood (1991) 0.91
Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost (1999) 0.91
Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz) (2012) 0.89
Circulating procoagulant microparticles in cancer patients. Ann Hematol (2010) 0.89
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res (2011) 0.89
Membrane microparticles in VTE and cancer. Thromb Res (2010) 0.86
Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. Thromb Res (2011) 0.86
Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. J Atheroscler Thromb (2009) 0.85
Circulating microparticles and risk of venous thromboembolism. Thromb Res (2011) 0.84
Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb Res (2008) 0.84
Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. Arch Cardiovasc Dis (2010) 0.83
Cell-derived microparticles: 'Miniature envoys with many faces'. J Thromb Haemost (2005) 0.80
[Microparticles during sepsis and trauma. A link between inflammation and thrombotic processes]. Ann Fr Anesth Reanim (2006) 0.78
Tissue factor-bearing microparticles and cancer. Semin Thromb Hemost (2008) 0.78
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications. Am J Hematol (1998) 0.75